Episodes
THIS INTERVIEW HAS EXPIRED
Published 05/02/19
Published 02/21/19
Interview with CEO Adam Burk
Published 02/12/19
Processa Pharmaceuticals
(OTC: PCSA)
CEO: David Young
Published 02/12/19
Stem Holdings
(OTCQB: STMH)
(CSE: STEM)
CEO: Adam Berk
Published 02/12/19
Clear Blue Technologies International
(TSXV: CBLU)
CEO: Miriam Tuerk
Published 02/08/19
Regulus Resources
(TSXV: REG)
(OTC: RGLSF)
CEO: John Black
Published 02/08/19
Eve & Co Inc
(TSXV: EVE)
(OTCQB EEVVF)
CEO: Melinda Rombouts
Published 02/08/19
Onconova Therapeutics
(NASDAQ: ONTX)
CEO: Steve Fruchtman
Published 02/01/19
Patriot One Technologies
(TSXV: PAT)
(OTCQX: PTOTF)
CEO: Martin Cronin
Published 02/01/19
Lightwave Logic
(OTC: LWLG)
CEO: Dr. Michael Lebby
Published 01/31/19
MediXall Group
(OTCQB: MDXL)
CEO: Michael Swartz
SVP Marketing: Vincent Caputo
Published 01/30/19
Medicine Man Technologies
(OTCQX: MDCL)
CEO: Andy Williams
Published 01/30/19
Enwave Corporation
(OTC: NWVCF)
(TSXV: ENW)
CEO: Brent Charleton
Published 01/29/19
Natural Shrimp, Inc
(OTCQB: SHMP)
CEO: Bill Williams
Published 01/28/19
Stornoway Diamonds
(TSX: SWY)
(OTC: SWYDF)
CEO: Patrick Godin
Published 01/25/19
Generex Biotechnology
(OTC: GNBT)
CEO: Joe Moscato
Published 01/22/19
Marathon Gold Corp
(TSX: MOZ)
(OTCQX: MGDPF)
CEO: Phil Walford
About: Marathon is a Toronto based gold exploration company rapidly advancing its 100% owned Valentine Lake Gold Camp located in Newfoundland, one of the top mining jurisdictions in the world. The Valentine Lake Gold Camp currently hosts four near-surface, mainly pit-shell constrained, deposits. The majority of the resources occur in the Marathon and Leprechaun deposits, which also have resources below the pit shell. The...
Published 01/18/19
Citius Pharmaceuticals
(NASDAQ: CTXR)
CEO: Myron Holubiak
About: Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and expanded indications for previously approved pharmaceutical products as a means to achieve leading market position or market exclusivity. By using previously approved drugs with substantial safety and efficacy data,...
Published 01/17/19
Marker Therapeutics
(NASDAQ: MRKR)
CEO and President: Peter Hoang
Published 01/16/19
DURECT Corporation
(NASDAQ:DRRX)
President and CEO: Jim Brown
Published 12/04/18
Albireo Pharma, Inc.
(Nasdaq: ALBO)
CEO: Ron Cooper
Published 12/03/18
Leading Edge Materials Corp
(TSXV: LEM)
(OTC: LEMIF)
CEO: Blair Way
Published 11/29/18
Paramount Gold Nevada Corp
(NYSE: PZG)
Executive Chairman: John Seaberg
Published 11/28/18
Tecogen, Inc.
(NASDAQ: TGEB)
CEO: Benjamin Locke
Published 11/26/18
Listen now
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
